Imagine a world where you could never dine away from home, wear makeup, smell of sweet perfumes or eat a large percentage of food on store shelves. According to allergists at the American College of Allergy, Asthma and Immunology ...
Nov 8, 2012
0
0
Exposure to perfluorooctanoic acid (PFOA), a manmade chemical used in the manufacture of some common household products, appears to be associated with cardiovascular disease and peripheral arterial disease in a study of 1,216 ...
Sep 3, 2012
0
0
For 20 years, Laura Stewart, Ph.D., a professor in the Department of Kinesiology, Nutrition and Dietetics, at the University of Northern Colorado, has been exploring how exercise improves the immune system. Over the last ...
Jan 31, 2024
0
0
Several people across the country have recently been hospitalized after consuming mushroom gummies distributed by Australian brand Uncle Frog and made in the United States. Their reported symptoms included elevated heart ...
Jun 29, 2024
0
0
Tirzepatide, a medication authorized to treat obesity and/or type 2 diabetes, consistently reduces bodyweight regardless of the patient's body mass index (BMI before treatment), from the range of overweight to class III obesity.
Mar 13, 2024
0
0
Insomnia is costing the average U.S. worker 11.3 days, or $2,280 in lost productivity every year, according to a study in the September 1 issue of the journal Sleep. As a nation, the total cost is 252.7 days and $63.2 billion.
Sep 1, 2011
0
0
(HealthDay)— The sugar substitute xylitol may help you lose weight, but it can be deadly for your dog, the U.S. Food and Drug Administration warns.
Jul 21, 2019
0
3
An analysis of data from a previous study of more than 1,350 smokers intending to quit after a hospitalization found that those who reported using electronic cigarettes (e-cigarettes) during the study period were less likely ...
Mar 26, 2018
0
15
Preliminary results from a new study suggest that several sleep-related symptoms are associated with decreased work productivity.
Jun 4, 2018
0
7
Since its approval in April 2019, dacomitinib has been available for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor ...
Aug 19, 2019
0
3
